Madsen, K.M., A. Hviid, M. Vestergaard, D. Schendel, J. Wohlfahrt, P. Thorsen, J. Olsen, and M. Melbye. 2002. A population-based study of measles, mumps, and rubella vaccination and autism. Ugeskrift for Laeger 164(49):5741-5744.
McCavit, T.L., L. Xuan, S. Zhang, G. Flores, and C.T. Quinn. 2012. Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure. Pediatric Blood and Cancer 58(6):945-949.
Miller, E. 2012. Vaccine policy and safety surveillance in England and Wales. Presentation to Meeting 3 of the Institute of Medicine Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Washington, DC, May 29.
Miller, E., P. Waight, C.P. Farrington, N. Andrews, J. Stowe, and B. Taylor. 2001. Idiopathic thrombocytopenic purpura and MMR vaccine. Archives of Disease in Childhood 84(3):227-229.
Mini-Sentinel Coordinating Center. 2011. Mini-Sentinel distributed database “at a glance.” Silver Spring, MD: Food and Drug Administration, Sentinel Initiative. http://mini-sentinel.org/about_us/MSDD_At-a-Glance.aspx (accessed November 12, 2012).
Nguyen, M., R. Ball, K. Midthun, and T.A. Lieu. 2012. The Food and Drug Administration’s Post-licensure Rapid Immunization Safety Monitoring program: Strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Safety 21(Suppl 1):S291-S297.
NVAC (National Vaccine Advisory Committee). 2011. National Vaccine Advisory Committee draft white paper on the United States vaccine safety system. Unpublished. National Vaccine Advisory Committee, Washington, DC.
Pedersen, C.B., H. Gøtzsche, J.Ø. Møller, and P.B. Mortensen. 2006. The Danish Civil Registration System. Danish Medical Bulletin 53(4):441-449.
Poehling, K.A., P.G. Szilagyi, K. Edwards, E. Mitchel, R. Barth, H. Hughes, B. Lafleur, S.J. Schaffer, B. Schwartz, and M.R. Griffin. 2003. Streptococcus pneumoniae-related illnesses in young children: Secular trends and regional variation. Pediatric Infectious Disease Journal 22(5):413-418.
Poehling, K.A., P.G. Szilagyi, C.G. Grijalva, S.W. Martin, B. LaFleur, E. Mitchel, R.D. Barth, J.P. Nuorti, and M.R. Griffin. 2007. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 119(4):707-715.
Public Health Agency of Canada. 2006. Canadian immunization guide. Ottawa, Ontario, Canada: Public Health Agency of Canada.
Scheifele, D.W., S.A. Halperin, and CPS/Health Canada, Immunization Monitoring Program, Active (IMPACT). 2003. Immunization Monitoring Program, Active: A model of active surveillance of vaccine safety. Seminars in Pediatric Infectious Diseases 14(3):213-219.
Simonsen, L., D. Morens, A. Elixhauser, M. Gerber, M. Van Raden, and W. Blackwelder. 2001. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 358(9289):1224-1229.
Simonsen, L., R.J. Taylor, Y. Young-Xu, M. Haber, L. May, and K.P. Klugman. 2011. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio 2(1):1-10.
Statens Serum Institut. 2012. Statens Serum Institut. Copenhagen, Denmark: Statens Serum Institut. http://www.ssi.dk/English.aspx (accessed July 10, 2012).
Tate, J.E., L. Simonsen, C. Viboud, C. Steiner, M.M. Patel, A.T. Curns, and U.D. Parashar. 2008. Trends in intussusception hospitalizations among US infants, 1993-2004: Implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 121(5):e1125-e1132.